Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Athersys Inc (NQ: ATHX )

1.830 USD -0.050 (-2.66%)
Official Closing Price Updated: 5:59 PM EST, Jan 21, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Athersys Inc

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
First Week of March 19th Options Trading For Athersys (ATHX)
Investors in Athersys Inc (ATHX) saw new options become available this week, for the March 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ATHX options... 
Tags Stocks
From Market News Video
The Math Shows XBI Can Go To $186
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Market Briefing For Tuesday, Dec. 22
Big-caps remain extended, as bears continue 'fighting the Fed', even as for sure, a post-Expiration pause would be normal, but Tesla might mix that up. 
Tags Technology Stocks / Equities Pharma/Biotech
From Blogs - TalkMarkets
Why Athersys Stock Jumped Today
The biotech announced the enrollment of the first patient in a key clinical study. 
Tags ATHX Market News
From Motley Fool
4 Best Penny Stocks To Buy Right Now? Analyst Targets Up To 246%
Tags Market News
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Market Briefing For Monday, Dec. 21
History is replete with those who tried to make the market go their way at a time when more powerful forces argued otherwise. 
Tags Pharma/Biotech Stocks / Equities
From Blogs - TalkMarkets
4 Penny Stocks To Buy According To Analysts; 48%-463% Price Targets
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
12 Healthcare Stocks Moving In Wednesday's After-Market Session
Gainers Corcept Therapeutics (NASDAQ:CORT) shares rose 22.99% to $22.95 during Wednesday's after-market session. At the close, ... 
Tags ANPC DARE After/Hours Center
From Benzinga
The Week Ahead In Biotech: Supernus, Sanofi Await FDA Decisions
Biotech stocks turned around with the broader market in the week ended Nov. 6, as investors warmed to the idea of a split Congress and a ... 
Tags XNCR HSDT RPRX
From Benzinga
44 Stocks Moving In Wednesday's Mid-Day Session
Gainers Spi Energy Co Ltd (NASDAQ: SPI) shares climbed 718.5% to $8.43 after the company launched a new electric vehicle ... 
Tags MNOV MICT UA
From Benzinga
Return On Capital Employed Overview: Athersys
During Q2, Athersys's (NASDAQ: ATHX) reported sales totaled $84.00 thousand. Despite a 16.36% in earnings, the company posted a loss ... 
Tags News Market News Penny Stocks
From Benzinga
The Daily Biotech Pulse: Coronavirus Vaccine Updates From J&J & MediciNova, Australian Regulatory Nod For GW Pharma
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags DBVT MRK NAOV
From Benzinga
38 Stocks Moving in Wednesday's Pre-Market Session
Gainers Predictive Oncology Inc. (NASDAQ: POAI) shares rose 43.1% to $1.21 in pre-market trading after the company secured ... 
Tags TSLA POAI SUNW
From Benzinga
First Week of ATHX November 20th Options Trading
Investors in Athersys Inc (ATHX) saw new options become available this week, for the November 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ATHX options... 
Tags Stocks
From Market News Video
The Math Shows XBI Can Go To $161
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Sum Up The Pieces: VHT Could Be Worth $228
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Athersys (ATHX) Q2 2020 Earnings Call Transcript
ATHX earnings call for the period ending June 30, 2020. 
Tags Market News ATHX
From Motley Fool
The Week Ahead In Biotech: Bausch Health, Fennec Pharma FDA Decisions And Smid-cap Earnings
Biotech stocks advanced in the week ended Aug. 7, buoyed by multiple catalysts. Aside from the broader market strength, mostly positive ... 
Tags PIRS ORGO RDUS
From Benzinga
Block-Buster SAR-CoV2 Disrupters Pre-ICU / Admitted ICU Patient Treatments & COVID-19 T-Cell Vaccine Horizon
In recent months, there has been a flurry of activity within the clinical trial sector. When all trial types are considered, there are over 400 studies exploring approaches to diagnosing, treating, or... 
Tags Healthcare Stocks / Equities Pharma/Biotech
From Blogs - TalkMarkets
Market Briefing For Tuesday, July 21
Tuesday may be a bit skittish but we see this market moving higher even as the case counts do as well; and it's not incongruous as to how this battle rages both for humanity and the weapons to fight... 
Tags Stocks / Equities Technology ETFs
From Blogs - TalkMarkets
First Week of ATHX September 18th Options Trading
Investors in Athersys Inc (ATHX) saw new options begin trading this week, for the September 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ATHX options... 
Tags Stocks
From Market News Video
Analysts Anticipate PBSM To Hit $29
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
64 Biggest Movers From Yesterday
Gainers Ekso Bionics Holdings, Inc. (NASDAQ: EKSO) shares jumped 135.3% to close at $7.30 after the company received FDA ... 
Tags DADA Movers HHT
From Benzinga
Here's Why Athersys Stock Is Soaring Today
The stem cell stock jumped after a major Wall Street firm initiated coverage, but there's a catch. 
Tags Market News ATHX
From Motley Fool
Top Buys by Directors: Traub's $322.5K Bet on ATHX
The directors of a company tend to have a unique inside view into the business, so when directors make major buys, investors are wise to take notice. Presumably the only reason a director of a company... 
Tags Stocks
From Market News Video
46 Stocks Moving In Thursday's Mid-Day Session
Gainers Ekso Bionics Holdings, Inc. (NASDAQ: EKSO) shares climbed 133% to $7.22 after the company received FDA clearance to ... 
Tags ELA VIE QURE
From Benzinga
Afternoon Market Stats in 5 Minutes
Movers Indices • S&P 500 ETF (NYSE:SPY) fell 0.10% to $303.98. • Nasdaq ETF (NASDAQ:QQQ) increased 0.03% to ... 
Tags DRI SPY QQQ
From Benzinga
Thursday's ETF Movers: XBI, EMLP
In trading on Thursday, the SPDR— S&P— Biotech ETF is outperforming other ETFs, up about 1.5% on the day. Components of that ETF showing particular strength include shares of Athersys, up about 26.8%... 
Tags ETFs
From ETF Channel
Thursday Sector Leaders: Grocery & Drug Stores, Biotechnology Stocks
In trading on Thursday, grocery & drug stores shares were relative leaders, up on the day by about 2%. Leading the group were shares of GNC Holdings, up about 28.2% and shares of Rite Aid up about... 
Tags Stocks
From Market News Video
Benzinga's Top Upgrades, Downgrades For June 25, 2020
Upgrades Credit Suisse changed the rating forAllstate Corp(NYSE: ALL) from Underperform to Neutral. Allstate ... 
Tags SEDG MKSI VSLR
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.